ArticleJournal of thoracic disease2026
Clinical characteristics and survival of esophageal cancer patients: annual report of the surgical treatment at Shanghai Chest Hospital, 2018.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal cancer remains a major health burden in China, and surgical resection is the cornerstone of curative treatment. Continuous annual reports from high-volume centers provide valuable benchmarks for evaluating temporal changes in surgical practice and outcomes. This report summarizes the clinical characteristics, perioperative outcomes and survival of patients who underwent surgical or endoscopic treatment for esophageal cancer at Shanghai Chest Hospital (SCH) in 2018. Methods: We retrospectively analyzed patients treated in 2018 based on data from the prospectively maintained SCH esophageal cancer database. Baseline demographics, treatment modality, pathological findings, postoperative complications, and survival outcomes were collected. The 2016 and 2017 SCH cohorts were included for descriptive temporal comparison. Results: A total of 714 patients underwent surgical treatment in 2018, including 654 esophagectomies and 60 endoscopic resections. Among the esophagectomy cohort, squamous cell carcinoma predominated (87.0%), and pathological T3 tumors accounted for 42.0%. Pathological nodal involvement was present in 51.7% of patients, with a median of 19 lymph nodes examined. Perioperative multidisciplinary treatment was conducted in 368 esophagectomy patients and four endoscopic submucosal dissection patients. In the esophagectomy cohort, minimally invasive approaches accounted for 80.6% of procedures. Postoperative complications after esophagectomy occurred in 33.9% of patients, with major complications (Clavien-Dindo ≥ III) in 11.5%; pleural effusion (11.0%) and recurrent laryngeal nerve injury (10.9%) were the most frequent specific complications. Thirty-day and 90-day mortality were low (0.7% and 1.8%, respectively). Five-year overall survival and cancer-specific survival were 53.8% and 59.9%, respectively. Conclusions: The 2018 SCH experience demonstrated a transition toward minimally invasive techniques and centralized care without compromising oncologic adequacy or short-term safety. Compared with 2016-2017, 2018 presented a modest shift toward superficial primary tumor invasion, a stable nodal burden, and a complication profile that may reflect evolving procedure mix and case selection. Continued prospective quality monitoring and data-driven refinement of perioperative management are warranted to further optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.